We reportthe optimal binding of Acumitin, Agathisflavone, Agehoustin B, and alpha-Toxicarol with aldose reductase for further consideration in drug discovery for T2DM. This evidence concerns the gene AKR1B1 and type 2 diabetes mellitus.